Skip to main content

Silexion Therapeutics Corp 8-K, filed Sep 29, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-09-29 For: 2026-09-28
View Original
Added on September 29, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on September 29, 2026, reporting on events of September 28, 2026.

Silexion Therapeutics Corp expects approximately $0.84 million in gross proceeds from 3,216,928 warrant exercises at $0.2603 per share and will issue 3,216,928 Series F warrants and 3,216,928 Series G warrants to purchase up to 6,433,856 ordinary shares at $0.2603 per share. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 3.02: Unregistered sale of equity
  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits